The British National Health Service on Tuesday issued new guidance permanently prohibiting the prescription of puberty blockers for children for the purposes of gender transition.
“We have concluded that there is not enough evidence to support the safety or clinical effectiveness of puberty suppressing hormones to make the treatment routinely available at this time,” an NHS spokesperson said in a statement obtained by the Washington Examiner.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
